Cargando…
A longitudinal analysis of the progression from normal blood pressure to stage 2 hypertension: A 12-year Korean cohort
BACKGROUND: The study aimed to estimate the incidence of and period of progression to stage 2 hypertension from normal blood pressure. METHODS: We selected a total of 21,172 normotensive individuals between 2003 and 2004 from the National Health Insurance Service-Health Screening and followed them u...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788775/ https://www.ncbi.nlm.nih.gov/pubmed/33407273 http://dx.doi.org/10.1186/s12889-020-10115-7 |
_version_ | 1783633097199190016 |
---|---|
author | Yu, Eun Sun Hong, Kwan Chun, Byung Chul |
author_facet | Yu, Eun Sun Hong, Kwan Chun, Byung Chul |
author_sort | Yu, Eun Sun |
collection | PubMed |
description | BACKGROUND: The study aimed to estimate the incidence of and period of progression to stage 2 hypertension from normal blood pressure. METHODS: We selected a total of 21,172 normotensive individuals between 2003 and 2004 from the National Health Insurance Service-Health Screening and followed them up until 2015. The criteria for blood pressure were based on the American College of Cardiology/American Heart Association 2017 guideline (normal BP: SBP < 120 and DBP < 80 mmHg, elevated BP: SBP 120–129 and DBP < 80 mmHg, stage 1 hypertension: SBP 130–139 or DBP 80–89 mmHg, stage 2 hypertension: SBP ≥140 or DBP ≥ 90 mmHg). We classified the participants into four courses (Course A: normal BP → elevated BP → stage 1 hypertension→ stage 2 hypertension, Course B: normal BP → elevated BP → stage 2 hypertension, Course C: normal BP → stage 1 hypertension → stage 2 hypertension, Course D: normal BP → stage 2 hypertension) according to their progression from normal blood pressure to stage 2 hypertension. RESULTS: During the median 12.23 years of follow-up period, 52.8% (n= 11,168) and 23.6% (n=5004) of the participants had stage 1 and stage 2 hypertension, respectively. In particular, over 60 years old had a 2.8-fold higher incidence of stage 2 hypertension than 40–49 years old. After the follow-up period, 77.5% (n=3879) of participants with stage 2 hypertension were found to be course C (n= 2378) and D (n=1501). After the follow-up period, 77.5% (n=3879) of participants with stage 2 hypertension were found to be course C (n= 2378) and D (n=1501). The mean years of progression from normal blood pressure to stage 2 hypertension were 8.7±2.6 years (course A), 6.1±2.9 years (course B), 7.5±2.8 years (course C) and 3.2±2.0 years, respectively. CONCLUSIONS: This study found that the incidence of hypertension is associated with the progression at each stage. We suggest that the strategies necessary to prevent progression to stage 2 hypertension need to be set differently for each target course. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-020-10115-7. |
format | Online Article Text |
id | pubmed-7788775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77887752021-01-07 A longitudinal analysis of the progression from normal blood pressure to stage 2 hypertension: A 12-year Korean cohort Yu, Eun Sun Hong, Kwan Chun, Byung Chul BMC Public Health Research Article BACKGROUND: The study aimed to estimate the incidence of and period of progression to stage 2 hypertension from normal blood pressure. METHODS: We selected a total of 21,172 normotensive individuals between 2003 and 2004 from the National Health Insurance Service-Health Screening and followed them up until 2015. The criteria for blood pressure were based on the American College of Cardiology/American Heart Association 2017 guideline (normal BP: SBP < 120 and DBP < 80 mmHg, elevated BP: SBP 120–129 and DBP < 80 mmHg, stage 1 hypertension: SBP 130–139 or DBP 80–89 mmHg, stage 2 hypertension: SBP ≥140 or DBP ≥ 90 mmHg). We classified the participants into four courses (Course A: normal BP → elevated BP → stage 1 hypertension→ stage 2 hypertension, Course B: normal BP → elevated BP → stage 2 hypertension, Course C: normal BP → stage 1 hypertension → stage 2 hypertension, Course D: normal BP → stage 2 hypertension) according to their progression from normal blood pressure to stage 2 hypertension. RESULTS: During the median 12.23 years of follow-up period, 52.8% (n= 11,168) and 23.6% (n=5004) of the participants had stage 1 and stage 2 hypertension, respectively. In particular, over 60 years old had a 2.8-fold higher incidence of stage 2 hypertension than 40–49 years old. After the follow-up period, 77.5% (n=3879) of participants with stage 2 hypertension were found to be course C (n= 2378) and D (n=1501). After the follow-up period, 77.5% (n=3879) of participants with stage 2 hypertension were found to be course C (n= 2378) and D (n=1501). The mean years of progression from normal blood pressure to stage 2 hypertension were 8.7±2.6 years (course A), 6.1±2.9 years (course B), 7.5±2.8 years (course C) and 3.2±2.0 years, respectively. CONCLUSIONS: This study found that the incidence of hypertension is associated with the progression at each stage. We suggest that the strategies necessary to prevent progression to stage 2 hypertension need to be set differently for each target course. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-020-10115-7. BioMed Central 2021-01-06 /pmc/articles/PMC7788775/ /pubmed/33407273 http://dx.doi.org/10.1186/s12889-020-10115-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Yu, Eun Sun Hong, Kwan Chun, Byung Chul A longitudinal analysis of the progression from normal blood pressure to stage 2 hypertension: A 12-year Korean cohort |
title | A longitudinal analysis of the progression from normal blood pressure to stage 2 hypertension: A 12-year Korean cohort |
title_full | A longitudinal analysis of the progression from normal blood pressure to stage 2 hypertension: A 12-year Korean cohort |
title_fullStr | A longitudinal analysis of the progression from normal blood pressure to stage 2 hypertension: A 12-year Korean cohort |
title_full_unstemmed | A longitudinal analysis of the progression from normal blood pressure to stage 2 hypertension: A 12-year Korean cohort |
title_short | A longitudinal analysis of the progression from normal blood pressure to stage 2 hypertension: A 12-year Korean cohort |
title_sort | longitudinal analysis of the progression from normal blood pressure to stage 2 hypertension: a 12-year korean cohort |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788775/ https://www.ncbi.nlm.nih.gov/pubmed/33407273 http://dx.doi.org/10.1186/s12889-020-10115-7 |
work_keys_str_mv | AT yueunsun alongitudinalanalysisoftheprogressionfromnormalbloodpressuretostage2hypertensiona12yearkoreancohort AT hongkwan alongitudinalanalysisoftheprogressionfromnormalbloodpressuretostage2hypertensiona12yearkoreancohort AT chunbyungchul alongitudinalanalysisoftheprogressionfromnormalbloodpressuretostage2hypertensiona12yearkoreancohort AT yueunsun longitudinalanalysisoftheprogressionfromnormalbloodpressuretostage2hypertensiona12yearkoreancohort AT hongkwan longitudinalanalysisoftheprogressionfromnormalbloodpressuretostage2hypertensiona12yearkoreancohort AT chunbyungchul longitudinalanalysisoftheprogressionfromnormalbloodpressuretostage2hypertensiona12yearkoreancohort |